Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

ILC development: TCF-1 reporting in

Nature Immunology volume 16, pages 1011–1012 (2015)Cite this article

Subjects

The transcriptional regulator TCF-1 marks rare progenitor cells in adult bone marrow that have lost the potential to develop into the lymphocyte lineage but can give rise to all innate lymphoid cell lineages.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Pathway of ILC development in adult bone marrow.

References

  1. Yang, Q.L. et al. Nat. Immunol. 16, 1044–1050 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Artis, D. & Spits, H. Nature 517, 293–301 (2015).

    Article  CAS  PubMed  Google Scholar 

  3. Yagi, R. et al. Immunity 40, 378–388 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Klose, C.S. et al. Cell 157, 340–356 (2014).

    Article  CAS  PubMed  Google Scholar 

  5. Constantinides, M.G., McDonald, B.D., Verhoef, P.A. & Bendelac, A. Nature 508, 397–401 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Aliahmad, P., de la Torre, B. & Kaye, J. Nat. Immunol. 11, 945–952 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Seehus, C.R. et al. Nat. Immunol. 16, 599–608 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Yu, X., et al. Elife 3, (2014).

  9. Weber, B.N. et al. Nature 476, 63–68 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wong, S.H. et al. Nat. Immunol. 13, 229–236 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Cherrier, M., Sawa, S. & Eberl, G. J. Exp. Med. 209, 729–740 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Xu, W. et al. Cell Rep 10, 2043–2054 (2015).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jonathan Kaye is in the Research Division of Immunology, Departments of Biomedical Sciences and Medicine, and the Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA, David Geffen School of Medicine, University of California, Los Angeles, California, USA.,

    Jonathan Kaye

Authors
  1. Jonathan Kaye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan Kaye.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaye, J. ILC development: TCF-1 reporting in. Nat Immunol 16, 1011–1012 (2015). https://doi.org/10.1038/ni.3276

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.3276

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing